|Min SIP Amount||Not Supported|
|NAV||₹10.45 (18 Jun 2021)|
|Fund Started||18 Jun 2018|
|Fund Size||₹32 Cr|
|Sun Pharmaceutical Inds. Ltd.||Healthcare||Equity||4.0%|
|HDFC Bank Ltd.||Financial||Fixed Deposits||3.6%|
|Tata Power Co. Ltd.||Energy||Equity||3.5%|
|ICICI Bank Ltd.||Financial||Equity||3.4%|
|Housing Development Finance Corpn. Ltd.||Financial||Equity||2.8%|
|Dabur India Ltd.||FMCG||Equity||2.7%|
|Hindalco Industries Ltd.||Metals||Equity||2.6%|
BOI AXA Arbitrage Fund Regular IDCW Yearly is a Hybrid Mutual Fund Scheme launched by BOI AXA Mutual Fund. This scheme was made available to investors on 18 Jun 2018. Ajay Khandelwal is the Current Fund Manager of BOI AXA Arbitrage Fund Regular IDCW Yearly fund.The fund currently has an Asset Under Management(AUM) of ₹32 Cr and the Latest NAV as of 18 Jun 2021 is ₹10.45.
The BOI AXA Arbitrage Fund Regular IDCW Yearly is rated Low risk. Exit load of 0.50% if redeemed within 30 days.
To generate income through arbitrage opportunities between cash and derivative segments of the equity market and arbitrage opportunities within the derivative segment and by deployment of surplus cash in debt securities and money market instruments.However, there is no assurance or guarantee that the investment objective of the scheme will be realized.